Monday, 6 July 2026
PCOS renaming proposal discussion, Long-term care workforce crisis, State surveillance of reproductive tech
- 01
Discussion on Renaming PCOS to PMOS Gains Attention
The authors of a correspondence in The Lancet address the proposal to rename polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS). They emphasise the importance of a consensus process that includes input from patients and health professionals worldwide. The discussion reflects evolving perspectives on the condition, focusing on scientific accuracy and stigma avoidance. This change in nomenclature could influence clinical practice and patient engagement.
via The Lancet
- 02
Crisis Looms for Long-Term Care Workforce in Aging America
The New England Journal of Medicine has published an ahead-of-print article discussing the impending crisis in the long-term care workforce in the United States. This issue is particularly relevant as it impacts healthcare delivery and policy, especially for general practitioners managing aging patients. The article highlights the challenges posed by an aging population and the strain on long-term care services. Further details on the implications and proposed solutions are not provided in the source.
via NEJM
- 03
Concerns Over State-Level Surveillance of Assisted Reproductive Technology
The New England Journal of Medicine has published an article discussing the implications of mandated state-level surveillance of assisted reproductive technology in the United States. This development raises significant public health and ethical concerns. The article highlights the potential impact on patient privacy and the regulation of reproductive health services. The discussion is timely as it addresses emerging threats to reproductive rights and healthcare practices.
via NEJM
- 04
Call for Recognition of Dual Expertise in Nursing
A nurse clinician-scientist advocates for the recognition of dual expertise within the nursing profession, highlighting its prevalence yet structural invisibility. The commentary references barriers to acknowledging lived experience in psychiatry, which also affect nursing. This discussion may influence collaborative care models in general practice by addressing workforce dynamics.
via The Lancet
- 05
Obituary: Influential Child Psychiatrist Judith Rapoport Dies at 92
Judith Rapoport, a prominent figure in child psychiatry, passed away on March 7, 2026, at the age of 92 due to lung cancer. Born on July 12, 1933, in New York City, she made significant contributions to mental health practices. Her work has had a lasting impact on the field, influencing approaches to child mental health. Rapoport's legacy continues to resonate within the medical community.
via The Lancet
- 06
Correction issued for prasinezumab study in Parkinson's disease
The Lancet has issued a correction to the appendix of a study evaluating the efficacy and safety of intravenous prasinezumab in early-stage Parkinson's disease patients on stable symptomatic monotherapy. This phase 2b, multicentre, randomised, double-blind, placebo-controlled study was conducted by Nikolcheva et al. The correction was made on July 2, 2026. This update is relevant for clinicians following advancements in Parkinson's disease treatments.
via The Lancet
MDDR is a news digest for medical professionals. It is not medical advice and should not be relied on for clinical decision-making.